Ferndale Laboratories, Inc.

Prescribe Pramosone E™ for Fast Relief of Itch Associated with Atopic Dermatitis

• Pramosone E™ uniquely combines pramoxine HCl anesthetic to relieve overall itch with hydrocortisone acetate to reduce inflammation

• Pramosone E™ has a high lipid content - delivered by Hydroplipid Technology™, a unique reverse phase formulation of 70% lipids dispersed in 30% outer phase of water.

Important Safety Information
Pramosone E™ (Hydrocortisone Acetate 2.5% and Pramoxine HCI 1%) Cream is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. Prolonged use may produce reversible HPA suppression. May cause local adverse reactions including burning, itching, irritation and dryness.

Full product information

Pramosone® Lotion 1% and 2.5%
Package Insert

Pramosone® Cream 1%
Package Insert

Pramosone® Cream 2.5%
Package Insert

Pramosone® Ointment 1% and 2.5%
Package Insert

Pramosone E™ Cream 2.5%
Package Insert

Ferndale Laboratories, Inc. is an Equal Opportunity Employer.

The products described herein may have different product labeling in different countries. The information provided at this site is intended only for residents of the United States. The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a health care provider and consider the unique characteristics of the patient.